Displaying items by tag: division of cardiovascular disease

A new multi-institutional study looks at the negative effects of a high-carbohydrate diet on the heart.
Springing forward with daylight saving time may increase your risk of having a heart attack if you have a history of heart disease.
UAB’s Suzanne Oparil, M.D., has been selected as one of only three doctors from the United States to receive the Clinical Excellence Award at the National Physician of the Year Awards in New York City.
UAB cardiovascular disease researchers are improving our understanding of the disease and finding new ways to provide medical care to patients.
94-year-old Wade Gladden came to UAB with only 20 percent heart function, but physicians put a months long plan in place to restore function — and the Gadsden resident hit every mark along the way.
Treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including heart attack, heart failure and stroke, by 25 percent.
The UAB-HudsonAlpha Center for Genomic Medicine has awarded its first pilot grants to teams of researchers from the two institutions to pursue projects in cancer and cardiac disease.
UAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.
Cardiologist Kevin Sublett will oversee the nationally accredited UAB Heart and Vascular Clinic of Central Alabama.
The protective effect is achieved by reducing acute inflammation in the spleen and the left ventricle of the heart.
Research revealing new evidence about the role of the spleen following heart attack will be honored during the AHA scientific meeting Nov. 15-19.
Symposium attendees will gain a better understanding of the most recent developments in the fields of clinical and basic science research in cardiovascular disease.
UAB Distinguished Professor’s editorial highlights research efforts exploring low-sodium intake guidelines and implications on cardiac disease and mortality.
UAB Hospital is the first in Alabama to offer the Nanostim™ leadless pacemaker for patients with bradycardia.
A new NIH grant could allow researchers to better predict risk factors for patients using blood-thinners by examining the influence of genes, lifestyle, clinical factors and environment.

The event is sponsored by the UAB Division of Cardiovascular Disease, Department of Medicine and Division of CME.

Success of ACE inhibitors, alpha blockers, calcium channel blockers and diuretics same in women and men with hypertension; diuretic superior in reducing cardiovascular complications.

The professorship was made possible by a gift from the United Therapeutics Corporation.

Page 10 of 11